Teon Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Twin Dolphin Dr Ste 120, Redwood Cit...Phone Number
(650) 486-1902Website
www.teontherapeutics.comRevenue
<$5 MillionIndustry
About Teon Therapeutics
Teon Therapeutics is focused on developing once-daily, oral cancer medications aimed at restoring anti-tumor immunity, allowing patients to prioritize what matters most in their lives. The company targets untapped metabolic signaling pathways to improve outcomes for cancer patients, particularly those with solid tumors who are underserved by current immunotherapy options. With a strong clinical-stage pipeline of GPCR-directed therapies, Teon is committed to addressing significant unmet needs in cancer care through innovative treatments. Their mission is driven by a dedicated leadership team with extensive experience in oncology drug development and a passion for transforming the treatment landscape.Explore more
Teon Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Teon Therapeutics
Compare insights from companies similar to Teon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Teon Therapeutics Tech Stack
A closer look at the technologies used by Teon Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teon Therapeutics
Sign Up For FreeTo access detailed company insights
Teon Therapeutics is focused on developing once-daily, oral cancer medications aimed at restoring anti-tumor immunity, allowing patients to prioritize what matters most in their lives. The company targets untapped metabolic signaling pathways to improve outcomes for cancer patients, particularly those with solid tumors who are underserved by curren... Read More
